Nick Leschly - Nov 11, 2021 Form 4 Insider Report for 2seventy bio, Inc. (TSVT)

Signature
/s/ Teresa Jurgensen, Attorney-in-Fact
Stock symbol
TSVT
Transactions as of
Nov 11, 2021
Transactions value $
$0
Form type
4
Date filed
11/16/2021, 05:43 AM
Previous filing
Oct 18, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TSVT Common Stock Award $0 +2.46K $0.00 2.46K Nov 11, 2021 Direct F1, F2, F3
transaction TSVT Common Stock Award $0 +4.1K +166.68% $0.00 6.56K Nov 11, 2021 Direct F2, F3, F4
transaction TSVT Common Stock Award $0 +8K +121.88% $0.00 14.6K Nov 11, 2021 Direct F2, F3, F5
transaction TSVT Common Stock Award $0 +11.6K +79.6% $0.00 26.2K Nov 11, 2021 Direct F2, F3, F6
transaction TSVT Common Stock Award $0 +33K +126.33% $0.00 59.2K Nov 11, 2021 Direct F2, F3, F7
transaction TSVT Common Stock Award $0 +50.4K +35.79% $0.00 191K Nov 11, 2021 Direct F2, F3, F8, F9
holding TSVT Common Stock 15.2K Nov 11, 2021 Nick Leschly 2001 Trust F10
holding TSVT Common Stock 41K Nov 11, 2021 Nick Leschly Irrevocable GST Trust of 2019 F11

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TSVT Stock Option (right to buy) Award $0 +54.1K $0.00 54.1K Nov 11, 2021 Common Stock 54.1K $38.00 Direct F12, F13
transaction TSVT Stock Option (right to buy) Award $0 +54.1K $0.00 54.1K Nov 11, 2021 Common Stock 54.1K $151.25 Direct F12, F13
transaction TSVT Stock Option (right to buy) Award $0 +29.5K $0.00 29.5K Nov 11, 2021 Common Stock 29.5K $78.44 Direct F12, F13
transaction TSVT Stock Option (right to buy) Award $0 +36.1K $0.00 36.1K Nov 11, 2021 Common Stock 36.1K $117.40 Direct F12, F13
transaction TSVT Stock Option (right to buy) Award $0 +39.4K $0.00 39.4K Nov 11, 2021 Common Stock 39.4K $318.73 Direct F12, F14
transaction TSVT Stock Option (right to buy) Award $0 +32.8K $0.00 32.8K Nov 11, 2021 Common Stock 32.8K $209.06 Direct F12, F15
transaction TSVT Stock Option (right to buy) Award $0 +21.3K $0.00 21.3K Nov 11, 2021 Common Stock 21.3K $114.67 Direct F12, F16
transaction TSVT Stock Option (right to buy) Award $0 +58K $0.00 58K Nov 11, 2021 Common Stock 58K $44.17 Direct F12, F17
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In connection with the separation (the "Separation") of seventy bio, Inc. ("2seventy") from bluebird bio, Inc. ("bluebird"), the reporting person received restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnote 16). This restricted stock unit award vests over a four-year period at a rate of 25% on 01/04/2019, 25% on 01/04/2020, 25% on 01/04/2021, and 25% on 01/04/2022.
F2 bluebird equity awards granted prior to January 1, 2021 were converted into equity awards of both bluebird and 2seventy. The number of shares underlying the converted bluebird equity awards was determined by multiplying the number of shares underlying the existing bluebird equity award by a fraction, the numerator of which is the volume-weighted average trading price of bluebird common stock (trading "regular way") on the five trading days immediately prior to the distribution date (the "bluebird Pre-Distribution VWAP"), the denominator of which is the sum of (1) the volume-weighted average trading price of 2seventy common stock (trading "regular way") on the five trading days immediately following the distribution date (the "2seventy VWAP") multiplied by the distribution ratio and (2) the volume-weighted average trading price of bluebird common stock (trading "regular way") on the five trading days immediately following the distribution date (the "bluebird Post-Distribution VWAP").
F3 The number of shares underlying the converted 2seventy equity awards was determined by multiplying the number of shares underlying the existing bluebird equity awards by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the sum of (1) the 2seventy VWAP multiplied by the distribution ratio and (2) the quotient obtained by dividing the bluebird Post-Distribution VWAP by the distribution ratio. bluebird equity awards granted on or after January 1, 2021, such equity awards were converted into 2seventy equity awards. The number of shares of 2seventy common stock underlying such converted equity awards is equal to the number of shares of bluebird common stock subject to the equity award immediately prior to the distribution multiplied by a fraction, the numerator of which is the bluebird Pre-Distribution VWAP and the denominator of which is the 2seventy VWAP.
F4 In connection with the Separation, the reporting person received a grant of restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests over a four-year period at a rate of 25% on 01/04/2020, 25% on 01/04/2021, 25% on 01/04/2022, and 25% on 01/04/2023 .
F5 In connection with the Separation, the reporting person received a grant of restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests over a four-year period at the rate of 25% on 01/04/2021, 25% on 01/04/2022, 25% on 01/04/2023, and 25% on 01/04/2024.
F6 In connection with the Separation, the reporting person received a grant of restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests over a four-year period at the rate of 25% on 01/04/2022, 25% on 01/04/2023, 25% on 01/04/2024, and 25% on 01/04/2025.
F7 In connection with the Separation, the reporting person received a grant of restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests over a two-year period at the rate of 40% on 08/02/2022 and 60% on 08/02/2023.
F8 In connection with the Separation, the reporting person received a grant of restricted stock units, each representing the right to receive a share of 2seventy's common stock, as a result of the adjustment of existing bluebird restricted stock units prior to the Separation (see footnotes 2 and 3). This restricted stock unit award vests upon the satisfaction of certain performance criteria.
F9 Includes 81,685 shares of 2seventy's common stock received in a pro rata distribution by bluebird as a result of the Separation.
F10 Represents 15,233 shares of 2seventy's common stock received by the Nick Leschly 2001 Trust in a pro rata distribution by bluebird as a result of the Separation.
F11 Represents 41,000 shares of 2seventy's common stock received by the Nick Leschly Irrevocable GST Trust of 2019 in a pro rata distribution by bluebird as a result of the Separation.
F12 Represents options to purchase shares of 2seventy's common stock granted to the reporting person in connection with the Separation (see footnotes 2 and 3).
F13 This option is fully vested and exercisable as of the date hereof (see footnotes 2 and 3).
F14 This option vests over a four-year period, at a rate of 25% on 01/04/2019 and in 36 equal monthly installments thereafter (see footnotes 2 and 3).
F15 This option vests over a four-year period, at a rate of 25% on 01/04/2020 and in 36 equal monthly installments thereafter (see footnotes 2 and 3).
F16 This option vests over a four-year period, at a rate of 25% on 01/04/2021 and in 36 equal monthly installments thereafter (see footnotes 2 and 3).
F17 This option vests over a four-year period, at a rate of 25% on 01/04/2022 and in 36 equal monthly installments thereafter (see footnotes 2 and 3).